Skip to main content
. 2018 Nov 24;23(12):3071. doi: 10.3390/molecules23123071

Figure 3.

Figure 3

Effect of kisspeptin-10 (100 nM–10 μM) treatment on extracellular dopamine (DA), norepinephrine (NE), and serotonin (5-hydroxytriptamine, 5-HT) levels, as determined by HPLC in rat hypothalamic (Hypo-E22) cell line (n = 5 individual culture flasks for each condition). Compared to control, kisspeptin-10 treatment significantly decreased extracellular DA (ANOVA, p < 0.01; post-hoc, ** p < 0.01 vs. control) and 5-HT (ANOVA, p < 0.01; post-hoc, ** p < 0.01 vs. control) levels.